Blue Earth Therapeutics
Blue Earth Therapeutics is a clinical stage radiopharmaceutical company focused on developing targeted radiotherapeutics for cancer treatment. They have a pipeline of precision targeted radiopharmaceuticals.
- Targeted radiopharmaceuticals
- Precision targeted radiotherapeutics
Locations
Digital Popularity
Social Media
Competitors
Oxular is transforming the treatment of retinal disorders to improve patients’ vision so they can live better lives.
Exscientia is a technology-driven company focused on AI drug discovery, aiming to revolutionise the pharmaceutical industry through precision medicine.
Nucleome Therapeutics is a biotechnology company focused on decoding the regulatory genome to develop first-in-class precision medicines.
Company Details
Blue Earth Therapeutics is operated by Blue Earth Therapeutics Limited and is a Active company incorporated on 26 February 2021 with the registered office located in Oxford, Oxfordshire. Blue Earth Therapeutics Limited was registered 4 years ago.
Status
Active
Size
Micro
Directors
10
Age
4 years old
Employees
6
Turnover
Unreported
Total Assets
£12M
Cash in Bank
£9.6M
Total Liabilities
-£3.03M
Teams
11
5
4
3
1
2
Chief Executive Officer • Joined Jul 2024
Chief Operating Officer & General Counsel • Joined Oct 2024
Head Of
Associate Director Pharmacovigilance • Joined Feb 2025
CMC Development Manager • Joined Jan 2025
Supply Chain Manager • Joined Nov 2024
Senior Clinical Trial Manager • Joined Dec 2024
Senior Director, Regulatory Affairs • Joined Jan 2024
Head Of CMC And Supply Chain • Joined Apr 2023
Medical Physicist • Joined Jun 2023
Chief Executive Officer • Joined Jul 2024
Chief Operating Officer & General Counsel • Joined Oct 2024
Head Of
Associate Director Pharmacovigilance • Joined Feb 2025
Senior Clinical Trial Manager • Joined Dec 2024
Senior Clinical Trial Manager • Joined Dec 2024
Medical Physicist • Joined Jun 2023
Medical Physicist • Joined May 2023
Senior Director, Regulatory Affairs • Joined Jan 2024
Chief Operating Officer & General Counsel • Joined Oct 2024
Head Of
Associate Director Pharmacovigilance • Joined Feb 2025
Supply Chain Manager • Joined Nov 2024
CMC Development Manager • Joined Jan 2025
Employee
View 11 members